Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia.

Dittrich T, Benner A, Kimmich C, Siepen FAD, Veelken K, Kristen AV, Bochtler T, Katus HA, Müller-Tidow C, Hegenbart U, Schönland SO.

Haematologica. 2019 Jul;104(7):1451-1459. doi: 10.3324/haematol.2018.205336. Epub 2019 Jan 17.

2.

Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis.

Ochs MM, Fritz T, Arenja N, Riffel J, Andre F, Mereles D, Siepen FAD, Hegenbart U, Schönland S, Katus HA, Friedrich MGW, Buss SJ.

J Cardiovasc Magn Reson. 2017 Nov 9;19(1):87. doi: 10.1186/s12968-017-0402-2.

3.

Predictors of survival stratification in patients with wild-type cardiac amyloidosis.

Siepen FAD, Bauer R, Voss A, Hein S, Aurich M, Riffel J, Mereles D, Röcken C, Buss SJ, Katus HA, Kristen AV.

Clin Res Cardiol. 2018 Feb;107(2):158-169. doi: 10.1007/s00392-017-1167-1. Epub 2017 Sep 27.

PMID:
28956153
4.

Limits of the possible: diagnostic image quality in coronary angiography with third-generation dual-source CT.

Ochs MM, Siepen FAD, Fritz T, Andre F, Gitsioudis G, Korosoglou G, Seitz S, Bogomazov Y, Schlett CL, Sokiranski R, Sommer A, Gückel F, Brado M, Kauczor HU, Görich J, Friedrich MGW, Katus HA, Buss SJ.

Clin Res Cardiol. 2017 Jul;106(7):485-492. doi: 10.1007/s00392-017-1077-2. Epub 2017 Feb 6.

PMID:
28168514

Supplemental Content

Loading ...
Support Center